Target antigens for prostate cancer CAR T cell therapy include prostate-specific antigen, prostate acid phosphatase, prostate-specific membrane antigen (PSMA), prostate stem cell antigen (PSCA), and epithelial cell adhesion molecule (EpCAM) [135, 136]. This evidence concerns the gene FOLH1 and prostate cancer.